Standout Papers
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia (2014)
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia (2013)
- Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy (2013)
- Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531 (2014)
Immediate Impact
7 by Nobel laureates 36 from Science/Nature 225 standout
Citing Papers
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
A new era of cancer phototherapy: mechanisms and applications
2024 Standout
Works of Richard Aplenc being referenced
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Richard Aplenc | 2638 | 2370 | 7923 | 3255 | 2888 | 316 | 13.0k | |
| Edward A. Stadtmauer | 6622 | 808 | 6730 | 5066 | 2130 | 330 | 13.7k | |
| Rosemarie Mick | 1463 | 1065 | 6092 | 3493 | 3164 | 262 | 14.1k | |
| Andreas Engert | 1931 | 1456 | 9034 | 2108 | 4065 | 551 | 20.2k | |
| Marcos de Lima | 9003 | 2801 | 3438 | 1916 | 2821 | 418 | 12.4k | |
| Matthew J. Maurer | 450 | 483 | 4760 | 4404 | 1388 | 476 | 13.6k | |
| Selina M. Luger | 5274 | 3131 | 2860 | 2848 | 1238 | 300 | 9.4k | |
| Daniel J. DeAngelo | 8805 | 4208 | 4155 | 6062 | 1800 | 438 | 15.9k | |
| Bipin N. Savani | 5766 | 1840 | 2873 | 1054 | 2620 | 361 | 8.7k | |
| Richard J. Jones | 7567 | 1387 | 4223 | 3296 | 3760 | 330 | 14.1k | |
| Ofer Shpilberg | 3196 | 791 | 3637 | 1814 | 1475 | 260 | 8.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...